Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

cdsco

  1. Home>
  2. News>
  3. cdsco>
  4. Page 13

India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026

  • Post published:July 3, 2026
  • Post category:Knowledge

India's reputation as the "Pharmacy of the World" rests on its ability to produce high-quality generic medicines at affordable prices. However, the past few years have exposed serious quality challenges…

Continue Reading India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026

Understanding CDSCO’s Generic Drug Approval Process: A 2026 Guide for Buyers

  • Post published:July 1, 2026
  • Post category:Knowledge

India's Central Drugs Standard Control Organization (CDSCO) is the national regulatory authority responsible for approving, monitoring, and regulating pharmaceutical products in the country. For international buyers seeking high-quality generic medicines…

Continue Reading Understanding CDSCO’s Generic Drug Approval Process: A 2026 Guide for Buyers

Understanding India’s Pharmaceutical Export Certification: A 2026 Buyer’s Guide

  • Post published:June 27, 2026
  • Post category:Knowledge

India, often called the "Pharmacy of the World," supplies over 20% of the global market for generic medicines and exports pharmaceutical products to more than 200 countries. However, for international…

Continue Reading Understanding India’s Pharmaceutical Export Certification: A 2026 Buyer’s Guide

India Pharma 2026: CDSCO Fast-Track Trials, Biosimilar Guidelines, and Innovation Agenda

  • Post published:June 27, 2026
  • Post category:News

The Indian pharmaceutical sector is undergoing a significant transformation in 2026, driven by landmark regulatory reforms from the Central Drugs Standard Control Organization (CDSCO), new clinical trial fast-track rules, updated…

Continue Reading India Pharma 2026: CDSCO Fast-Track Trials, Biosimilar Guidelines, and Innovation Agenda
  • Go to the previous page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 20
  • Go to the next page

Recent Posts

  • Schedule M 2026 Explained: GMP Compliance Rules for Indian Pharma
    September 13, 2026/
    0 Comments
  • CDSCO Adopts Risk-Based Drug Regulation Framework in India
    September 12, 2026/
    0 Comments
  • How to Verify Generic Medicine Quality: A Practical Buyer’s Checklist for India
    September 8, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • Schedule M 2026 Explained: GMP Compliance Rules for Indian Pharma
  • CDSCO Adopts Risk-Based Drug Regulation Framework in India
  • How to Verify Generic Medicine Quality: A Practical Buyer’s Checklist for India
  • Piyush Goyal Urges Indian Pharma to Move Beyond Generics into High-Value Medicines
  • Understanding India’s NDCT Rules 2026 Amendments: A Guide for Pharma Buyers

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve